Microbial ecology of swine farms and PRRS vaccine vaccination strategies

Vet Microbiol. 2012 Mar 23;155(2-4):247-56. doi: 10.1016/j.vetmic.2011.09.028. Epub 2011 Oct 1.

Abstract

The present study investigated the microbial ecology and vaccination strategies against porcine reproductive and respiratory syndrome (PRRS) in field condition. Four representative farms with a history of PRRS were included in this study. Over the almost 3-year period, the average detection rate was 68.9%, making PRRSV the first most frequently detected virus, followed by porcine circovirus type 2 (PCV2) (64.2%), pseudorabies virus (PRV) (11.03%) and classical swine fever virus (CSFV) (4.41%). Streptococcus suis (77.92%), Haemophilus parasuis (51.25%) and Escherichia coli (52.39%), Pasteurella multocida (26.77%) were isolated most frequently in association with PRRSV. Under the present microbial ecology, production performances of sows their offspring after mass vaccination with a PRRS attenuated vaccine were evaluated. In addition, large scale PRRS vaccines usage and efficacy were further performed. The results indicated that mass vaccination following our immunization program can improve health status and production performances of both sows (2ml/i.m. booster after 4 weeks, and then immunized quarterly) and their offsprings (1ml/i.m. on 14-18 days of age).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Circovirus / isolation & purification
  • Herpesvirus 1, Suid / isolation & purification
  • Male
  • Porcine Reproductive and Respiratory Syndrome / diagnosis
  • Porcine Reproductive and Respiratory Syndrome / prevention & control*
  • Porcine Reproductive and Respiratory Syndrome / virology*
  • Porcine respiratory and reproductive syndrome virus / immunology*
  • Porcine respiratory and reproductive syndrome virus / isolation & purification
  • Swine
  • Vaccination / veterinary
  • Vaccines, Attenuated / immunology
  • Viral Vaccines* / immunology

Substances

  • Vaccines, Attenuated
  • Viral Vaccines